Home
>
US Stocks
>
Connect Biopharma Holdings Ltd - ADR
Connect Biopharma Holdings Ltd - ADR
CNTB

Connect Biopharma Holdings Ltd - ADR (CNTB)

$16.57.07%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
16.82
Today Low/High
15.34 / 16.98
52 Week Low/High
$14.02 / $29.27
Market Cap
$954.57M

Company Details

Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients living with chronic inflammatory diseases through the development of therapies derived from its T cell-driven research. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα), which is a validated target for the treatment of several inflammatory diseases such as atopic dermatitis (AD) and asthma. Its second lead product candidate is CBP-307, a modulator of a T cell receptor known as sphingosine 1-phosphate receptor 1 (S1P1).
Organisation
Connect Biopharma Holdings Ltd - ADR

Discover more

Frequently Asked Questions

What is Connect Biopharma Holdings Ltd - ADR (CNTB) share price today?

Can Indians buy Connect Biopharma Holdings Ltd - ADR (CNTB) shares?

How can I buy Connect Biopharma Holdings Ltd - ADR (CNTB) shares from India?

Can Fractional shares of Connect Biopharma Holdings Ltd - ADR (CNTB) be purchased?

What are the documents required to start investing in Connect Biopharma Holdings Ltd - ADR (CNTB) stocks?

We are a SEBI registered investement advisor